Channels :: FRELIP Discovery

Author: Barth, Stefan

Quick Look
Development Of Recombinant Immunotherapeutics for Triple-Negative Breast Cancer (TNBC)

Similar Items: Development Of Recombinant Immunotherapeutics for Triple-Negative Breast Cancer (TNBC)

Quick Look
Establishment of enhanced protein purification strategies for recombinant immunotherapeutics
Quick Look
Next-Generation version of pseudomonas exotoxin a based immunotoxins with reduced immunogenicity for triple negative breast cancer (TNBC) treatment
Quick Look
Validation of an aASPH-SNAP-tag fusion protein for immunodiagnosis of triple-negative breast cancer
Quick Look
Protein Kinase C‐Delta (PKCδ) inhibition stabilizes endothelium and suppresses triple‐negative breast cancer (TNBC) intravasation in a microfluidic hypoxic tumor model
Quick Look
Generation and therapeutic evaluation of recombinant immunotherapeutics on CD64+ monocytic cell lines and polarized ex vivo differentiated human macrophages
Quick Look
Lipid profile and atherogenic indices in triple-negative breast cancer
Quick Look
Box-Behnken Design of Chitosan-NPs Encapsulating 5-Fluorouracil and Santalum album Essential Oil and Investigating their Combinatorial Therapeutic Effect against Triple Negative Breast Cancer (TNBC) cell line.
Quick Look
Spatial characterization of the BT-20 triple negative breast cancer spheroidal model
Quick Look
AIM2 Lactylation Regulates Radiotherapy Sensitivity in Triple-Negative Breast Cancer
Quick Look
Integrative Computational and Transcriptional Analysis of NF-κB and HIF-1α Modulation Following Doxorubicin Treatment in Triple-Negative Breast Cancer Cells
Quick Look
The cellular response of triple-negative breast cancer to short-term starvation: implications for chemosensitivity
Quick Look
The adenosine A receptor in triple-negative breast cancer: molecular mechanisms and therapeutic implications
Quick Look
Salidroside-Based Nanomedicines for Triple-Negative Breast Cancer: From Molecular Mechanisms to Clinical Translation
Quick Look
Toxicity outcomes of concurrent radiotherapy with adjuvant capecitabine in triple-negative breast cancer (TROD 06-24)
Quick Look
Mechanistic Evaluation of -Engineered Silver Nanoparticles Against Triple-Negative Breast Cancer and Biofilm-Forming Bacteria
Quick Look
Integrated network pharmacology reveal new key curcumin-binding targets in triple-negative breast cancer
Quick Look
The anti-cancer activity of a novel palladacycle, BTC2, in oestrogen receptor positive and triple negative breast cancers
Quick Look
Microenvironmental Cues That Regulate Cancer Cell Dormancy in Estrogen‐Receptor Positive and Triple‐Negative Breast Cancer Cell Lines
Quick Look
Targeting the CD47/Calreticulin axis in Triple Negative Breast Cancer using HA grafted Chitosan nanoparticles loaded with Doxorubicin and Polygodial
Quick Look
Development of potential immunodiagnostic & therapeutic techniques using SNAP-fusion proteins as tools for the validation of Triple-negative Breast Cancer
Quick Look
Genetic Correlation of miR-423 Polymorphism rs8067576 with Progression and Prognosis of Triple-Negative Breast Cancer
Quick Look
Integrated Analysis Identifies an Anoikis‐Related Gene Signature for Predicting Prognosis in Patients With Triple‐Negative Breast Cancer
Quick Look
LINC01128 Affects Triple-Negative Breast Cancer Progression Through Targeting miR-32-5p
Quick Look
A Curcumin‐Derived HSP70 Inhibitor Disrupts Lysosomal Function to Suppress Triple‐Negative Breast Cancer Progression